Pathogenesis and pathophysiology of meningitis

A R Tunkel1, B Wispelwey, W M Scheld

  • 1Division of Infectious Diseases, University of Virginia School of Medicine, Charlottesville.

Insights

Experimental animal models advance understanding of meningitis pathogenesis. These models investigate bacterial, fungal, and viral meningitis, paving the way for novel treatments.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Immunology

Background:

  • Meningitis pathogenesis and pathophysiology are primarily understood through experimental animal models.
  • These models are crucial for studying bacterial meningitis, focusing on virulence factors, central nervous system (CNS) invasion, and subarachnoid space (SAS) inflammation.

Purpose of the Study:

  • To review advances in understanding the pathogenesis and pathophysiology of bacterial, fungal, and viral meningitis.
  • To highlight the role of experimental animal models in this understanding.
  • To explore the potential for developing innovative treatment strategies based on these advances.

Main Methods:

  • Utilizing experimental animal models to study meningitis.
  • Investigating bacterial virulence factors and host inflammatory cytokine responses.
  • Examining the pathophysiology of CNS invasion and inflammation in bacterial, fungal (Cryptococcus neoformans), and viral meningitis.

Main Results:

  • Experimental models have elucidated bacterial virulence factors' roles in CNS infection and inflammation.
  • Host inflammatory cytokines are implicated in pathophysiological consequences like increased blood-brain barrier (BBB) permeability, cerebral edema, and intracranial pressure.
  • Understanding C. neoformans meningitis in immunocompromised individuals (e.g., AIDS) and viral meningitis mechanisms (hematogenous dissemination) is enhanced.

Conclusions:

  • Advances in understanding meningitis pathogenesis and pathophysiology through animal models are significant.
  • These insights into bacterial, fungal, and viral meningitis mechanisms offer potential for novel therapeutic strategies.
  • Further research using these models may lead to improved treatments for various forms of meningitis.

Related Concept Videos

Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...